Aurinia Pharmaceuticals Inc (AUPH)

[puravida]

Adam F admitted he was "dead wrong" on Ariad the morning of the buyout announcement after being called out on Twitter. Days earlier he had published his biotech winners/losers year in review article. he left ariad as a "undecided" because though it outperformed his expectations he was still right that it wasn't sold in 2016. (meaning no one wanted it) then we know what happened 1/09/17. So he did admit he was wrong, however if would have been more appropriate to actually publish something to the masses that he was dead wrong. He did write that Takeda overpaid for the company. lol

But enough about Ariad regarding Aurinia really hope an early buyout doesn't occur here. the recent volume and activity as well as Glickman's aggressive marketing stance have been awesome but if the company sells soon it would be unfortunate as we all know the deep value that could be generated with a fully matured voclosporin.

Imagine what Denner would have received for selling ariad with only ponatinib and a very young brigatinib. I remember Meg Tirrell interviewing him during Berger's tenure, Denner was superbullish on pona and had little to elaborate on brig and that there wasn't a rush to put the company on a flash sale and to be very bullish on the drugs but to be patient. Well that patience turned into a clearer bullish picture on Brigatinib as well as incredible shareholder value return

Now that we have seen that 48week data Aurinia is just getting started!